Age is a significant independent risk factor for cardiovascular death.19 Heart failure is more common in elderly individuals and is more common in older women than in older men.19 Our findings suggest that SGLT2-Is effectively reduce the outcome of cardiovascular death or HHF in patients in both age groups with similar risk reduction. Here, SLC5A2 is linked to heart failure.